Loading News...
Volver al Panel

Johnson & Johnson (JNJ)

Valores intradiarios en tiempo real

Resumen del Mercado

From:
To:
JNJ Intraday
No data available
SímboloJNJ
Fecha de SalidaJan 2, 1962
CEOMr. Joaquin Duato
Empleados a Tiempo Completo138.2k
SectorHealthcare
IndustriaDrug Manufacturers - General
PaísUnited States
BolsaNYSE
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Rendimiento
PeríodoRentabilidad %Cambio de Valor
1 Día
-1.41%
-3.77 US$
5 Días
+3.24%
+8.28 US$
1 Mes
-1.98%
-5.33 US$
6 Meses
+15.97%
+36.34 US$

Analizando el Mercado con IA

Evaluando los últimos 30 días de historial y métricas fundamentales de JNJ...

Estadísticas Clave
Cap. de Mercado
635.07B
Relación P/E
40.03
Rend. de Div.
2.03%
Máx. 52 Semanas
$281.07
Mín. 52 Semanas
$184.66

Consenso de Analistas

CONSENSOCompra
ALCISTA1669.6%
NEUTRAL626.1%
BAJISTA14.3%

Objetivos de Precios de Analistas a 52 Semanas

Objetivo Mín.
$190.00
Objetivo Máx.
$320.00
Actual$263.84
Objetivo Prom.$279.41

Recomendaciones de Analistas

Precio Objetivo:$279.41($190.00 - $320.00)
FirmaCalificaciónPrecio ObjetivoPotencial de AlzaFecha
Wells FargoOverweight$287.00+8.78%16/10/2026
Morgan StanleyOverweight$292.00+10.67%15/10/2026
Leerink PartnersOutperform$272.00+3.09%14/10/2026
Wells FargoOverweight$275.00+4.23%14/10/2026
RBC CapitalOutperform$280.00+6.12%14/10/2026
GuggenheimBuy$287.00+8.78%7/10/2026
RBC CapitalOutperform$290.00+9.92%6/10/2026
CitigroupBuy$303.00+14.84%5/10/2026
JP MorganNeutral$285.00+8.02%29/9/2026
HSBCBuy$320.00+21.29%10/9/2026
Pensamientos de la Comunidad

Comparta su análisis y sentimiento sobre JNJ

Únase a la comunidad para compartir su análisis